These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10909421)

  • 1. Inhibitors of tyrosine kinases in the treatment of psoriasis.
    Ben-Bassat H; Levitzki A
    Isr Med Assoc J; 2000 Jul; 2 Suppl():69-73. PubMed ID: 10909421
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.
    Ben-Bassat H
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1539-45. PubMed ID: 11763154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of tyrosine kinases in the treatment of psoriasis.
    Ben-Bassat H; Klein BY
    Curr Pharm Des; 2000 Jun; 6(9):933-42. PubMed ID: 10828317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?
    Wierzbicka E; Tourani JM; Guillet G
    Br J Dermatol; 2006 Jul; 155(1):213-4. PubMed ID: 16792781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic efficacy of treatments aimed at the EGF receptor].
    Armand JP; Milano G
    Bull Cancer; 2003 Nov; 90 Spec No():S177. PubMed ID: 14768620
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component.
    Lin YK; Leu YL; Yang SH; Chen HW; Wang CT; Pang JH
    J Dermatol Sci; 2009 Jun; 54(3):168-74. PubMed ID: 19303259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and electronic properties of tyrosine kinases inhibitors.
    Santillán MB; Tomás-Vert F; Aulló JM; Jáuregui EA; Ciuffo GM
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):929-37. PubMed ID: 14656050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New agents regulating tyrosine kinase can be used against several cancers.
    Morrow T
    Manag Care; 2004 May; 13(5):54-5. PubMed ID: 15181691
    [No Abstract]   [Full Text] [Related]  

  • 15. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
    El-Obeid A; Hesselager G; Westermark B; Nistér M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the EGFR in neoplasia--more questions than answers.
    Dicker AP; Rodeck U
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):899-902. PubMed ID: 14967449
    [No Abstract]   [Full Text] [Related]  

  • 18. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.
    Shushan A; Rojansky N; Laufer N; Klein BY; Shlomai Z; Levitzki R; Hartzstark Z; Ben-Bassat H
    Hum Reprod; 2004 Sep; 19(9):1957-67. PubMed ID: 15205403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrphostins suppress the growth of psoriatic keratinocytes.
    Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
    Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation.
    Thielitz A; Bukowska A; Wolke C; Vetter R; Lendeckel U; Wrenger S; Hashimoto Y; Ansorge S; Gollnick H; Reinhold D
    Biochem Biophys Res Commun; 2004 Sep; 321(4):795-801. PubMed ID: 15358097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.